• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类受体酪氨酸激酶RON的基因结构及肺癌样本中的突变分析

Gene structure of the human receptor tyrosine kinase RON and mutation analysis in lung cancer samples.

作者信息

Angeloni D, Danilkovitch-Miagkova A, Ivanov S V, Breathnach R, Johnson B E, Leonard E J, Lerman M I

机构信息

Laboratory of Immunobiology, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland.

出版信息

Genes Chromosomes Cancer. 2000 Oct;29(2):147-56.

PMID:10959094
Abstract

The human RON gene (MST1R) maps to 3p21.3, a region frequently altered in lung cancer and other malignancies. It encodes a receptor tyrosine kinase (RTK) closely related to MET, whose mutations are associated with neoplasia. We investigated whether RON might be involved in the development or progression of lung cancer. We first determined the exon-intron structure of the gene by direct sequencing of RON cosmid DNA and PCR products containing intronic sequences, and then developed primers suitable for mutation analysis by the single-strand conformation polymorphism (SSCP) method. Twenty coding exons were characterized, all but the first one small (average size: 170 bp), a feature shared with other RTK genes. We performed SSCP analysis of RON in small and non-small cell lung cancer samples, upon detection of its expression in a sample of lung cancer cell lines. A mutation (T915C: L296P) was found in an adenocarcinoma specimen. Several single nucleotide polymorphisms were also found. The panel of intron-anchored primers developed in this work will be useful for mutation analysis of the RON gene in different types of human tumors.

摘要

人类RON基因(MST1R)定位于3p21.3,该区域在肺癌和其他恶性肿瘤中经常发生改变。它编码一种与MET密切相关的受体酪氨酸激酶(RTK),其突变与肿瘤形成有关。我们研究了RON是否可能参与肺癌的发生或发展。我们首先通过对RON黏粒DNA和包含内含子序列的PCR产物进行直接测序来确定该基因的外显子-内含子结构,然后开发适用于单链构象多态性(SSCP)方法进行突变分析的引物。鉴定出20个编码外显子,除第一个外其余都很小(平均大小:170 bp),这是其他RTK基因共有的特征。在检测到其在一组肺癌细胞系样本中表达后,我们对小细胞肺癌和非小细胞肺癌样本进行了RON的SSCP分析。在一份腺癌标本中发现了一个突变(T915C:L296P)。还发现了几个单核苷酸多态性。在这项工作中开发的内含子锚定引物组将有助于对不同类型人类肿瘤中的RON基因进行突变分析。

相似文献

1
Gene structure of the human receptor tyrosine kinase RON and mutation analysis in lung cancer samples.人类受体酪氨酸激酶RON的基因结构及肺癌样本中的突变分析
Genes Chromosomes Cancer. 2000 Oct;29(2):147-56.
2
Novel splicing variants of recepteur d'origine nantais (RON) tyrosine kinase involving exons 15-19 in lung cancer.肺癌中涉及第15至19外显子的源自南特的受体(RON)酪氨酸激酶的新型剪接变体。
Lung Cancer. 2016 Feb;92:41-6. doi: 10.1016/j.lungcan.2015.12.002. Epub 2015 Dec 12.
3
Splice variants of the extracellular region of RON receptor tyrosine kinase in lung cancer cell lines identified by PCR and sequencing.通过 PCR 和测序鉴定肺癌细胞系中 RON 受体酪氨酸激酶胞外区的剪接变体。
BMC Cancer. 2017 Nov 9;17(1):738. doi: 10.1186/s12885-017-3747-x.
4
Macrophage-stimulating protein and its receptor in non-small-cell lung tumors: induction of receptor tyrosine phosphorylation and cell migration.巨噬细胞刺激蛋白及其受体在非小细胞肺癌中的作用:诱导受体酪氨酸磷酸化和细胞迁移。
Am J Respir Cell Mol Biol. 1998 Apr;18(4):489-96. doi: 10.1165/ajrcmb.18.4.2978.
5
Reduced transcription of the RB2/p130 gene in human lung cancer.人类肺癌中RB2/p130基因转录减少。
Mol Carcinog. 2003 Nov;38(3):124-9. doi: 10.1002/mc.10152.
6
High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.台湾肺癌鳞状细胞癌患者p53基因缺失突变的高频率
Cancer Res. 1998 Jan 15;58(2):328-33.
7
Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.Ron的点突变和过表达会诱导细胞转化、肿瘤形成和转移。
Oncogene. 2001 Sep 27;20(43):6142-51. doi: 10.1038/sj.onc.1204836.
8
Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.9号染色体短臂21区缺失的肺癌中Hel-N1的基因组结构与突变分析
Cancer Res. 1997 Dec 1;57(23):5356-9.
9
Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines.一组人结肠癌细胞系中RON受体酪氨酸激酶的过表达与激活
Exp Cell Res. 2000 Nov 25;261(1):229-38. doi: 10.1006/excr.2000.5012.
10
Identification of the splice variants of Recepteur d'Origine nantais (RON) in lung cancer cell lines.鉴定肺癌细胞系中 Recepteur d'Origine nantais(RON)的剪接变异体。
Gene. 2018 Dec 30;679:335-340. doi: 10.1016/j.gene.2018.09.027. Epub 2018 Sep 14.

引用本文的文献

1
Role of plectin and its interacting molecules in cancer.黏联蛋白及其相互作用分子在癌症中的作用。
Med Oncol. 2023 Aug 26;40(10):280. doi: 10.1007/s12032-023-02132-4.
2
Prognostic significance of pyroptosis-related factors in lung adenocarcinoma.肺腺癌中焦亡相关因子的预后意义
J Thorac Dis. 2022 Mar;14(3):654-667. doi: 10.21037/jtd-22-86.
3
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?当间皮瘤中的RON遇上TAM:是否所有靶点都可针对一种药物,而一种药物能针对所有靶点?
Front Endocrinol (Lausanne). 2019 Feb 26;10:89. doi: 10.3389/fendo.2019.00089. eCollection 2019.
4
Role of Recepteur D'origine Nantais on Gastric Cancer Development and Progression.南特起源受体在胃癌发生发展中的作用。
Chonnam Med J. 2017 Sep;53(3):178-186. doi: 10.4068/cmj.2017.53.3.178. Epub 2017 Sep 25.
5
A novel RON splice variant lacking exon 2 activates the PI3K/AKT pathway via PTEN phosphorylation in colorectal carcinoma cells.一种缺乏外显子2的新型RON剪接变体通过磷酸化PTEN激活结肠癌细胞中的PI3K/AKT信号通路。
Oncotarget. 2017 Jun 13;8(24):39101-39116. doi: 10.18632/oncotarget.16603.
6
RON kinase isoforms demonstrate variable cell motility in normal cells.RON 激酶异构体在正常细胞中表现出不同的细胞迁移能力。
Heliyon. 2016 Sep 6;2(9):e00153. doi: 10.1016/j.heliyon.2016.e00153. eCollection 2016 Sep.
7
Prognostic significance of MST1R dysregulation in renal cell tumors.MST1R失调在肾细胞肿瘤中的预后意义
Am J Cancer Res. 2016 Aug 1;6(8):1799-811. eCollection 2016.
8
Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.靶向RON酪氨酸激酶受体胞外结构域用于癌症治疗和药物递送的策略。
J Cancer Res Clin Oncol. 2016 Dec;142(12):2429-2446. doi: 10.1007/s00432-016-2214-4. Epub 2016 Aug 8.
9
A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells.RON酪氨酸激酶受体的一种新型蛋白质异构体可转化人胰腺导管上皮细胞。
Oncogene. 2016 Jun 23;35(25):3249-59. doi: 10.1038/onc.2015.384. Epub 2015 Oct 19.
10
SRSF2 promotes splicing and transcription of exon 11 included isoform in Ron proto-oncogene.SRSF2促进原癌基因Ron中包含外显子11的异构体的剪接和转录。
Biochim Biophys Acta. 2014 Nov;1839(11):1132-40. doi: 10.1016/j.bbagrm.2014.09.003. Epub 2014 Sep 8.